Live Price
Live Volume
Chart Volume 0
Volume 0
5 secTransCode Therapeutics Market Segments
Regular Trading Hours
-0.09(-4.74%)
| Open | $1.84 |
|---|---|
| Close | $1.75 |
| Low | $1.74 |
| Low Change | -0.10 (-5.28%) |
| High | $1.91 |
| High Change | +0.07 (+3.97%) |
| Range | $0.17 |
| Volume | 23.297K |
| Dollar Volume | $40.77K |
Premarket
+0.18(+10.84%)
| Open | $1.66 |
|---|---|
| Close | $1.84 |
| Low | $1.66 |
| Low Change | 0.00 (0.00%) |
| High | $1.84 |
| High Change | +0.18 (+10.84%) |
| Range | $0.18 |
| Volume | 330 |
| Dollar Volume | $607.20 |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.04(+2.30%)
| Open | $1.74 |
|---|---|
| Close | $1.78 |
| Low | $1.74 |
| Low Change | 0.00 (0.00%) |
| High | $1.85 |
| High Change | +0.11 (+6.32%) |
| Range | $0.11 |
| Volume | 5.234K |
| Dollar Volume | $9.32K |
Regular Trading Hours Yesterday
+0.14(+8.70%)
| Open | $1.61 |
|---|---|
| Close | $1.75 |
| Low | $1.61 |
| Low Change | 0.00 (0.00%) |
| High | $1.78 |
| High Change | +0.17 (+10.56%) |
| Range | $0.17 |
| Volume | 11.677K |
| Dollar Volume | $20.43K |
Premarket Yesterday
*No Trades in Segment
TransCode Therapeutics News
TransCode Therapeutics Top Trades
TransCode Therapeutics's top trade so far today returned +15.06%, while the top short trade returned -8.38%.
TransCode Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.72 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.72 |
| 20 Day Moving Average (SMA20) | $1.72 |
| 50 Day Moving Average (SMA50) | $1.91 |
| 100 Day Moving Average (SMA100) | $3.86 |
| 200 Day Moving Average (SMA200) | $6.24 |
TransCode Therapeutics Statistics
| Average Volume (30 Days) | 75.7K |
|---|---|
| P/E Ratio (Current) | -.68 |
| EPS (Current) | -$2.73 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$22.61M |
| Cash Ratio | 1.55 |
| Current Ratio | 1.97 |
| Quick Ratio | 1.97 |
| Debt to Equity | -0.02 |
| Enterprise Value | $23.76M |
| EV to EBITDA | -0.66 |
| EV to Sales | — |
| Price to Book | -1.14 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.31% |
| Return on Equity | 1.67% |
TransCode Therapeutics Stock Splits
There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.
| Date | Type | Ratio |
|---|---|---|
| May 15, 2025 | Reverse | 28:1 |
| Dec 4, 2024 | Reverse | 33:1 |
| Jan 16, 2024 | Reverse | 40:1 |
| May 23, 2023 | Reverse | 20:1 |
TransCode Therapeutics Dividends
There have been no dividends for TransCode Therapeutics (RNAZ).